Replies to post #64 on AccelPath Inc. (fka ACLP)

[Dominion Melchizedek]

This is hilarious. Ex Div date AFTER distribution and date of record. LOL!

Not only are these guys crooks, but they cant even read a calendar.

http://finance.yahoo.com/news/Technest-Announces-ExDividend-iw-344243222.html?x=0&.v=1

"Press Release Source: Technest Holdings Inc. On Monday January 4, 2010, 3:17 pm EST
BETHESDA, MD--(Marketwire - 01/04/10) - Technest Holdings, Inc. (OTC.BB:TCNH - News) announced that FINRA has determined that the ex-dividend date will be January 19, 2010 for the special "return of capital" cash distribution declared by its Board of Directors on December 23, 2009. The ex-dividend date is the date on or after which the security begins to trade without the right to receive the dividend payment. The cash dividend of $0.407 per share of Common Stock is payable on January 15, 2010 to shareholders of record as of January 4, 2010. This distribution relates to the sale of EOIR Technologies, Inc. as previously announced."

[Hedge Starz]

“We are excited about completing our business combination with Technest and will henceforth be identified as AccelPath. The Company continues to advance its software and hardware solutions aimed at enabling advanced tele-medical services,” said Shekhar Wadekar, the Company’s Chief Executive Officer.”
About AccelPath
AccelPath provides technology solutions that play a key role in delivering information required for diagnosis of diseases and other pathologic conditions with and through its associated institutional pathologists. The medical institutions, with whom the Company partners, prepare comprehensive diagnostic reports of a patient’s condition and consult with referring physicians to help determine the most appropriate treatment. Such diagnostic reports enable the early detection of disease, allowing referring physicians to make informed and timely treatment decisions that improve their patients’ health in a cost-effective manner. The Company seeks out referring physicians and histology laboratories in need of high-quality pathology interpretations and manages HIPAA-compliant digital case delivery and reporting while developing comprehensive solutions for managing medical information.